help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on May 29, 2007
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-0702
A more recent version of this article appeared on August 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
92/8/3219    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Das, S.
Right arrow Articles by McCarthy, M. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Das, S.
Right arrow Articles by McCarthy, M. I.
Related Collections
Right arrow Pediatric Endocrinology
Right arrow Metabolism

Submitted on March 27, 2007
Accepted on May 21, 2007

Detailed analysis of variation at and around mitochondrial position 16189 in a large Finnish cohort reveals no significant associations with early growth or metabolic phenotypes at age 31

Sreena Das, Amanda J. Bennett, Ulla Sovio, Aimo Ruokonen, Hannu Martikainen, Anneli Pouta, Anna-Liisa Hartikainen, Stephen Franks, Paul Elliott, Joanne Poulton*, Marjo-Riitta Järvelin, and Mark I. McCarthy

Women's Centre level 3, Nuffield Department of Obstetrics and Gynecology, John Radcliffe Hospital, University of Oxford, UK; Oxford Centre for Diabetes, Endocrinology & Metabolism, University of Oxford, UK; Dept of Epidemiology and Public Health, Imperial College London, UK; Dept of Clinical Chemistry, University of Oulu, Oulu, Finland; Dept of Obstetrics and Gynecology, University of Oulu, Oulu, Finland; National Public Health Institute, Oulu, Finland; Dept of Public Health Science and General Practice, University of Oulu, Oulu, Finland; Institute of Reproductive and Developmental Biology, Imperial College London, UK; Wellcome Trust Centre for Human Genetics, University of Oxford, UK

* To whom correspondence should be addressed. E-mail: joanna.poulton{at}obs-gyn.ox.ac.uk.

Context: Mitochondrial dysfunction is increasingly-implicated in pathogenesis of adult metabolic disease. Rare mitochondrial (mt) DNA mutations impair glucose homeostasis, but the contribution of common variants is unclear. In small studies, variation within the OriB origin of replication (at mt16189 in particular) has been associated with both early growth and adult metabolic phenotypes and may contribute to life-course relationships between the two.

Objective: To study a large well-characterised cohort to determine whether previously-reported small-scale associations between OriB sequence variation and early growth and adult metabolic phenotypes are robust.

Design/Setting/ Participants: Genetic association study in 5470 individuals from the population-based, Northern Finland Birth Cohort of 1966, followed prospectively from pregnancy to age 31.

Main Outcome Measures: Indices of early growth (including birth weight, placental weight, and ponderal index) and adult metabolic homeostasis (including BMI, fasting glucose and insulin, indices of insulin action and secretion) and their relationship to variation in the OriB region.

Results: Previously-reported associations could not be confirmed. There were no significant (P < 0.01, uncorrected) associations between OriB sequence variation and measures of early growth including birthweight (P = 0.52, comparing individuals with mt16189T to those with a homopolymeric C-tract) and placental weight (P = 0.49). There were no significant associations with adult metabolic phenotypes including fasting glucose (P = 0.07), fasting insulin (P = 0.42) and homeostatic model assessment-derived measures of insulin sensitivity or secretion (P = 0.45 and P = 0.56 respectively).

Conclusion: Despite substantial power to detect previously-reported effects, mtDNA variations around OriB are not major contributors to variation in early growth and metabolic phenotypes during early adulthood.


Key words: Mitochondria • early growth phenotypes • metabolic disease







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society